How to improve delivery of care in patients with heart failure

Cardiology Journal

Volumn 14, Issue 6, 2007, Pages 521-522

  Gradus Pizlo, Irmina ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACCESS TO INFORMATION; ARTIFICIAL HEART PACEMAKER; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EDITORIAL; EDUCATION PROGRAM; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEART FAILURE; HUMAN; MEDICAL EDUCATION; MEDICAL SPECIALIST; MONOTHERAPY; MORTALITY; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PHYSICAL PERFORMANCE; POLAND;

EID: 39549113645     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. American Heart Association. Heart Disease and Stroke Statistics 2004 Update. American Heart Association, Dallas, TX 2004.
2. Fedyk-Łukasik M, Zdrojewski T, Wizner B et al. Heart failure management in Poland: the National Cardiovascular Disease Prevention and Treatment Program POLKARD, edition 2003-2005. Cardiol J, 2007; 14: 552-560.
3. Cohn JN, Carson PE, O'Connor C et al. Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT. Congest Heart Fail, 2006; 12: 127-131.
4. Stevenson LW, Massie BM, Francis GS et al. Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J, 1998, 135 (6 Part 2): S293-S309.
5. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant, 1994; 13 (suppl.): 107-112.
6. Gattis WA, O'Connor CM, Gallup DS et al. Predischargwe initiation of carvedilol in patients hospitalized for decompensated heart failure: Results of the Initiation Management Predischarge: process for Assessment of carvedilol Therapy in Heart failure (IMPACT-HF) trial. J Am Coll Cardiol, 2004; 43: 1534.